Monopar Therapeutics
MNPR
#7582
Rank
A$0.72 B
Marketcap
A$106.25
Share price
-0.94%
Change (1 day)
-9.18%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -A$26.28 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$20.25 Million, an increase over its 2024 earnings that were of -A$23.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$26.28 Million29.81%
2025 -A$20.25 Million-11.99%
2024 -A$23.01 Million85.5%
2023 -A$12.4 Million-20.1%
2022 -A$15.52 Million15.52%
2021 -A$13.44 Million44.39%
2020 -A$9.31 Million49.23%
2019 -A$6.24 Million28.04%
2018 -A$4.87 Million-80.07%
2017 -A$24.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA